THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- Orthofix International Completes Divestiture of Sports Medicine Business Unit
- ConforMIS iTotal CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence Awards
- Health Canada Authorizes New Aurora Plasma Collection System from Fenwal Inc.
- Medtronic Resolute Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
- Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
- More Press Releases
Featured Jobs
-
Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA -
Scientist II Job
Yoh - Niskayuna, NY, USA -
Biostatistician (Entry Level) - Permanent Job
Yoh - Tarrytown, NY, USA -
Director, Marketing IBS Franchise
Prometheus - San Diego, CA -
Associate Director, Manufacturing Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Comments